1Amin F, Davidson M,Kahn RS,et al. Assessment of the central dopaminergie index of plasma HVA in schizophrenia. Schizophrenia Bulletin, 1995,21 ( 1 ) :53- 66.
5Arana GW. An overview of side effects caused by typical antipsyehotica.J Clin Psyehiatry,2000,61 ( Suppl 8 ) :5 - 11.
6Wirshing DA,Pierre JM,Fahart SM,et al. Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psyehiat Clin North Am,2003,26( 1 ) :165 - 190.
7Montgomery JH, Tekell JL. Adjunctive quetiapine treatment of the polydipsia,intermittent hyponatremia, and psychosis syndrome: a case report. J Clin Psychiatry,2003,64 ( 3 ) :339 - 341.
8Keks NA. Minimizing the non-extrapyramidal side effects of antipsychotics. Acta Psychiatr Scand,1996,94( 1 ) :18 -24.
9Csemansky JG. Treatment of schizophrenia:preventing the progression of disease. Psychiatr Clin North Am, 2003,26 ( 2 ) :367 -379.
10Bradley PB, Hirsch SR. The psychopharmaeology and treatment of schizophrenia. 1^st Oxford: Oxforf medical publications, 1986. 417 -418.
